Physician profile
Gerald Pohost
NPI 1871534636
$1,163.50
in general payments reported to CMS, 2019-2025
23 companies · $25.60 in 2025
The $25.60 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $143 · 2021: $364 · 2022: $167 · 2025: $25.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $175.48 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Pfizer INC. | $113.16 | 2019 | |
| Allergan, INC. | $97.48 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.41 | 2021-2022 | |
| Abbott Laboratories | $74.05 | 2022 | |
| Siemens Medical Solutions USA, INC. | $72.87 | 2019 | |
| Novo Nordisk INC | $45.15 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $39.49 | 2022-2025 | Assure Wcd |
| Amgen INC. | $37.75 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $36.03 | 2021 | |
| Currax Pharmaceuticals LLC | $34.97 | 2021 | |
| Boston Scientific Corporation | $30.57 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.55 | 2019 | |
| Abbvie INC. | $21.78 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $20.45 | 2019 | |
| Arbor Pharmaceuticals, INC. | $20.30 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.19 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.86 | 2021 | |
| Medtronic, INC. | $17.85 | 2022 | |
| Merck Sharp & Dohme LLC | $16.87 | 2019 | |
| Tactile Systems Technology INC | $14.99 | 2020 | |
| Itamar Medical INC | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Pohost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.